New Search

Your search found 26 records, sorted by year and then date of acquisition.

1. Utilizing a Two-Stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-Daily Bupropion as a Treatment for Methamphetamine Use Disorder. doc type
  Mooney, Larissa J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Ang, Alfonso ; Sharma, Gaurav ; Terry, Garth ; Chang, Linda ; Walker, N. Robrina ; Trivedi, Madhukar H. ; Croteau, David ; Sparenborg, Steven ; Ling, Walter
 Journal of Addiction Medicine 2016;10(4):236-243. [doi: 10.1097/ADM.0000000000000218].
 
2. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
3. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
4. Treatment Satisfaction in the CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Thomas, Christie ; Hillhouse, Maureen P. ; Ang, Alfonso ; Annon, Jeffrey J. ; Mooney, Larissa J. ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
5. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
6. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
7. Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females. doc type
  Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
 Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].
 
8. Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users. doc type
  Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
9. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
10. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
11. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
12. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
13. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
14. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
15. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial. doc type
  Back, Sudie E. ; Payne, Rebecca ; Wahlquist, Amy Herrin ; Carter, Rickey E. ; Stroud, Zachary ; Haynes, Louise F. ; Hillhouse, Maureen P. ; Brady, Kathleen T. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):313-323. [doi: 10.3109/00952990.2011.596982].
 
16. Participant Characteristics and Buprenorphine Dose. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Doraimani, Geetha ; Thomas, Christie ; Hasson, Albert L. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):453-459. [doi: 10.3109/00952990.2011.596974].
 
17. Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. doc type
  Chen, Hanhui ; Hillhouse, Maureen P. ; Doraimani, Geetha ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
18. START Study Retention: Perspectives of Suboxone Dropouts. doc type
  Teruya, Cheryl ; Thomas, Christie ; Rosensteel, Anya ; Hasson, Albert L. ; Hillhouse, Maureen P. ; Hser, Yih-Ing ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
19. Implementing Research in Community Treatment Programs: Findings from a CTN Trial. doc type
  Cohen, Allan J. ; George, Dan ; Langlois, Camille ; Moreno, Ann ; Yomjinda, Dara ; Boubion, Cynthia ; Martin, Judith ; Donovick, Roger ; Thomas, Christie ; Hasson, Albert L. ; Vimieiro, Cintia ; Hillhouse, Maureen P. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
20. Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. doc type
  Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen P. ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie
 Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587].
 
21. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
22. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
23. Provision of Ancillary Medications During Buprenorphine Detoxification Does Not Improve Treatment Outcomes. doc type
  Hillhouse, Maureen P. ; Domier, Catherine P. ; Chim, David ; Ling, Walter
 Journal of Addictive Diseases 2010;29(1):23-29. [doi: 10.1080/10550880903438925].
 
24. Gender Differences at Presentation for Treatment-Seeking Opiate Dependence. doc type
  Haynes, Louise F. ; Carter, Rickey E. ; Back, Sudie E. ; Payne, Rebecca ; Hillhouse, Maureen P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
25. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
26. A Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. doc type doc type
  Ling, Walter ; Amass, Leslie ; Shoptaw, Steven ; Annon, Jeffrey J. ; Hillhouse, Maureen P. ; Babcock, Dean ; Brigham, Gregory S. ; Harrer, Judith M. ; Reid, Malcolm S. ; Muir, Joan A. ; Buchan, Betty J. ; Orr, Deborah ; Woody, George E. ; Krejci, Jonathan ; Ziedonis, Douglas M. ; CTN Buprenorphine Study Team (CTN-0001/0002)
 Addiction 2005; 100(8):1090-1100. [doi: 10.1111/j.1360-0443.2005.01154.x] Correction: Addiction 2006;101(9):1374.